Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Gabriel, Figueroa-Parra"'
Autor:
Ali Duarte-García, Larry J Prokop, Gabriel Figueroa-Parra, María C Cuéllar-Gutiérrez, Mariana González-Treviño, M Hassan Murad
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss Suppl 2 (2024)
Externí odkaz:
https://doaj.org/article/12519aca9b134d88926d843da486caf8
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss 1 (2024)
Objective We aimed to evaluate the robustness of phase III randomised controlled trials (RCTs) for SLE and lupus nephritis (LN) using the fragility index (FI), the reverse FI (RFI) and the fragility quotient (FQ).Methods We searched for phase III RCT
Externí odkaz:
https://doaj.org/article/e5a90622aabc4a89a780995e3fa026e2
Autor:
Farah Tamirou, Frederic Houssiau, Ali Duarte-García, Maria Dall’Era, Brad H Rovin, Larry J Prokop, Gabriel Figueroa-Parra, Cynthia S Crowson, Michael S Putman, Fernando C Fervenza, Alain Sanchez-Rodriguez, María C Cuéllar-Gutiérrez, Mariana González-Treviño, Jaime Flores-Gouyonnet, José A Meade-Aguilar, M Hassan Murad
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss Suppl 1 (2024)
Externí odkaz:
https://doaj.org/article/a3eee3392158483083aac4b060fe6fad
Autor:
Ali Duarte-García, Gabriel Figueroa-Parra, Elena Myasoedova, Cynthia S Crowson, John M Davis, Andrew C Hanson, Baptiste Chevet, Daniel Montes, Cassondra A Hulshizer
Publikováno v:
RMD Open, Vol 9, Iss 4 (2023)
Objectives The objective is to examine utilisation of cardiovascular preventive services in patients with rheumatoid arthritis (RA), compared with a non-RA population, and to examine cardiovascular disease (CVD) screening rates among RA patients with
Externí odkaz:
https://doaj.org/article/9d19e8ef3c324c37a0b8532beab128be
Autor:
Zesheng An, Gabriel Figueroa-Parra, Xian Zhou, Yanfeng Li, Jane Jaquith, Kathleen McCarthy-Fruin, Jennifer Sletten, Kenneth J. Warrington, Cornelia Weyand, Cynthia S. Crowson, Saranya Chumsri, Keith L. Knutson, Alain Sanchez-Rodriguez, Uma Thanarajasingam, Alí Duarte-García, Hu Zeng
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionThe longitudinal responses towards multiple doses of COVID-19 mRNA vaccines in patients with systemic autoimmune diseases remain incompletely understood. While observational studies suggested the safety of COVID-19 mRNA vaccines in rheuma
Externí odkaz:
https://doaj.org/article/525d025c062e4bb49ae18fa17d36f9a9
Autor:
Baptiste Chevet, Gabriel Figueroa-Parra, Jeffrey X. Yang, Mehmet Hocaoglu, Shirley-Ann Osei-Onomah, Cassondra A. Hulshizer, Tina M. Gunderson, Divi Cornec, Kamil E. Barbour, Kurt J. Greenlund, Cynthia S. Crowson, Alí Duarte-García
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-13 (2022)
Abstract Background Systemic lupus erythematosus (SLE) is a disease that can lead to damage of multiple organs and, along with certain treatments, increase the risk of developing cancer, cardiovascular disease, diabetes, osteoporosis, and infections.
Externí odkaz:
https://doaj.org/article/c2c8133c0b0d47b19b7453a553af4313
Autor:
Ali Duarte-García, Gabriel Figueroa-Parra, Molly M Jeffery, Rozalina McCoy, Cynthia Crowson, Maria Stevens, Herbert Heien, Jose Meade, Uma Thanarajasingam
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 3 (2022)
Externí odkaz:
https://doaj.org/article/ad21065e636249618353d4f8cb0f8cdc
Autor:
Gabriel Figueroa-Parra, Andrea Moreno-Salinas, Leticia Santoyo-Fexas, Carmen Gamboa-Alonso, Juan Carrizales-Luna, Ivan Hernandez-Galarza, Dionicio Galarza-Delgado, Jorge Esquivel-Valerio
Publikováno v:
Rheumatology, Vol 59, Iss 6, Pp 362-366 (2021)
Externí odkaz:
https://doaj.org/article/d686fef43dcc49ff9e1a7f7957f4c27a
Autor:
Gabriel Figueroa-Parra, Jorge Antonio Esquivel-Valerio, Leticia Santoyo-Fexas, Andrea Moreno-Salinas, Carmen Magdalena Gamboa-Alonso, Ana Laura De Leon-Ibarra, Dionicio Angel Galarza-Delgado
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 5, Pp 1420-1425 (2021)
Patients with rheumatic diseases (RD) have a higher risk of morbidity and mortality from vaccine-preventable infections attributed to disease activity, comorbidities, immunosuppressive therapy, and other factors. Vaccines are one of the safest and mo
Externí odkaz:
https://doaj.org/article/23a5ececb01f45cb944958155924a093
Autor:
Gabriel, Figueroa-Parra, Emily L, Gilbert, Maria O, Valenzuela-Almada, Sebastian, Vallejo, Matthew R, Neville, Naomi J, Patel, Claire, Cook, Xiaoqing, Fu, Ramla, Hagi, Gregory C, McDermott, Michael A, Dilorio, Lucy, Masto, Kathleen M M, Vanni, Emily, Kowalski, Grace, Qian, Yuqing, Zhang, Zachary S, Wallace, Alí, Duarte-García, Jeffrey A, Sparks
Publikováno v:
The Lancet Rheumatology. 4:e765-e774
Rheumatoid arthritis has been associated with severe COVID-19, but few studies have investigated how phenotypes of rheumatoid arthritis affect these associations. We aimed to investigate the associations between rheumatoid arthritis and phenotypes of